304 related articles for article (PubMed ID: 31746067)
1. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
Gupta AK; Stec N; Bamimore MA; Foley KA; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):580-588. PubMed ID: 31746067
[TBL] [Abstract][Full Text] [Related]
2. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
3. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
5. Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis.
Gupta AK; Foley KA; Mays RR; Shear NH; Piguet V
Br J Dermatol; 2020 Feb; 182(2):287-299. PubMed ID: 31120134
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Gupta AK
Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
[TBL] [Abstract][Full Text] [Related]
7. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Gupta AK; Ryder JE; Johnson AM
Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
[TBL] [Abstract][Full Text] [Related]
8. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
9. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
10. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
[TBL] [Abstract][Full Text] [Related]
11. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
12. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
Gupta AK; Lynch LE; Kogan N; Cooper EA
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
[TBL] [Abstract][Full Text] [Related]
13. Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis.
Shemer A; Gupta AK; Kamshov S; Babaev M; Hermush V; Farhi R; Daniel CR; Foley KA
J Dermatolog Treat; 2021 May; 32(3):310-313. PubMed ID: 31415182
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
[TBL] [Abstract][Full Text] [Related]
16. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Evans EG; Sigurgeirsson B
BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Jansen R; Redekop WK; Rutten FF
Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
[TBL] [Abstract][Full Text] [Related]
18. Terbinafine: a review of its use in onychomycosis in adults.
Darkes MJ; Scott LJ; Goa KL
Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Kejda J
Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
[TBL] [Abstract][Full Text] [Related]
20. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]